Transwarranty Finance ESOP Grant, Capital Increase

Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI LODR Regulations

Employee Stock Option Scheme:

Nomination Remuneration and Compensation Committee and Board approved grant of 2,96,040 stock options to eligible employees under Employee Stock Option Scheme 2019
Each option convertible into one equity share of face value ₹10 each when exercised
Exercise price based on latest available closing price prior to grant date on stock exchange with highest trading volume
Vesting period as per Transwarranty ESOP Plan 2019
Exercise period: Five years from date of vesting
Scheme compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Capital Structure Changes:

Board approved increase in authorized share capital from ₹61,00,00,000 (61,00,000 equity shares of ₹10 each) to ₹65,00,00,000 (65,00,000 equity shares of ₹10 each)
Subject to shareholder approval at ensuing Annual General Meeting
Requires alteration of Capital clause of Memorandum of Association and Articles of Association

Historical ESOP Exercise Data:

Options exercised to date: 14,41,657 equity shares
Money realized from exercise of options: ₹1,44,16,570
Paid-up share capital increased to 55,116,194 shares as result of option exercises
Options lapsed: Not Applicable
Variation of terms: Not Applicable
Subsequent changes/cancellation: Not Applicable
Diluted EPS impact: Not Applicable